Metraipolis › archive › dc_4caa2af33ed8
Phase I trial and pharmacokinetic study of berubicin (RTA 744) in patients with recurrent or refractory high-grade gliomas — Europe PMC PMID:42569309
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42569309
- DOI
- 10.1093/noajnl/vdag150
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T06:38:06.786Z
- SHA-256 of the archived text
905ab77deb4dfed26607333ad546a685ada7d1df3e24fc2d9313edcad21c67c8- Stable URL of this page
https://metraipolis.com/documento/dc_4caa2af33ed8
How to cite
Phase I trial and pharmacokinetic study of berubicin (RTA 744) in patients with recurrent or refractory high-grade gliomas — Europe PMC PMID:42569309 — Europe PMC (en), https://europepmc.org/article/MED/42569309 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4caa2af33ed8 (Metraipolis archive dc_4caa2af33ed8, sha256 905ab77deb4dfed26607333ad546a685ada7d1df3e24fc2d9313edcad21c67c8)
BibTeX
@misc{dc4caa2af33ed8,
title = {Phase I trial and pharmacokinetic study of berubicin (RTA 744) in patients with recurrent or refractory high-grade gliomas — Europe PMC PMID:42569309},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42569309},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4caa2af33ed8; sha256 905ab77deb4dfed26607333ad546a685ada7d1df3e24fc2d9313edcad21c67c8},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42569309. Agents can read the archived copy with the MCP tool read_document.